Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Mannose 6-Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mannose 6-Phosphate SCHEMBL28885847 | 1.00 | MPI (0.52) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL48152 | 1.00 | MPI (0.52) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL21632784 | 1.00 | MPI (0.52) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL9231707 | 0.98 | MPI (0.50) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL21693684 | 0.98 | MPI (0.50) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL21693687 | 0.98 | MPI (0.50) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL21693710 | 0.98 | MPI (0.50) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL21693713 | 0.98 | MPI (0.50) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL9234969 | 0.98 | MPI (0.50) | MPIPGD | |
| Mannose 6-Phosphate SCHEMBL21693697 | 0.98 | MPI (0.50) | MPIPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120201991-A | Composition for improving skin wrinkles | 株式会社LG生活健康 | 2025-06-24 | — | — | CN | claimed |
| EP-3946243-B1 | ANTI-AGING COSMETIC COMPOSITION | GIVAUDAN SA (CH) | 2024-06-26 | — | — | EP | claimed |
| WO-2024106669-A1 | COMPOSITION FOR IMPROVING SKIN WRINKLES | 주식회사 엘지생활건강 | 2024-05-23 | — | — | WO | claimed |
| EP-4272724-A1 | SUBSTANCE COMBINATION FOR COSMETIC PREPARATIONS | La Prairie Group AG (CH) | 2023-11-08 | — | — | EP | claimed |
| US-20220160607-A1 | ANTI-AGING COSMETIC COMPOSITIONS | GIVAUDAN SA (CH) | 2022-05-26 | — | — | US | claimed |
| CN-113645947-A | Anti-aging cosmetic composition | 奇华顿股份有限公司 | 2021-11-12 | — | — | CN | claimed |
| US-20250277274-A1 | MICROBIOME SIGNATURE | GIVAUDAN SA (CH) | 2025-09-04 | — | — | US | disclosed |
| CN-120201991-A | Composition for improving skin wrinkles | 株式会社LG生活健康 | 2025-06-24 | — | — | CN | disclosed |
| CN-119015158-B | Cosmetic composition for enhancing mitochondrial energy, application and cosmetic | 广东省禾基生物科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| WO-2025044163-A1 | ANTI-AGING COMPOSITION FOR REMODELING DERMAL STRUCTURE, PREPARATION METHOD THEREFOR AND USE THEREOF | 诺德溯源(广州)生物科技有限公司 | 2025-03-06 | — | — | WO | disclosed |
| WO-2025048546-A1 | COMPOSITION FOR IMPROVING SKIN CONDITION | 주식회사 엘지생활건강 | 2025-03-06 | — | — | WO | disclosed |
| CN-119015158-A | Cosmetic composition for enhancing mitochondrial energy, application and cosmetic | 广东省禾基生物科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| EP-3946243-B1 | ANTI-AGING COSMETIC COMPOSITION | GIVAUDAN SA (CH) | 2024-06-26 | — | — | EP | disclosed |
| WO-2011117126-A2 | SKIN-FRIENDLY ACTIVE INGREDIENT COMBINATION TO COMBAT ACNE | BEIERSDORF AG (DE) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011112421-A2 | PROBIOTIC COLOR COSMETIC COMPOSITIONS AND METHODS | ELC MANAGEMENT LLC (US) | 2011-09-15 | — | — | WO | disclosed |
| US-20110223219-A1 | Probiotic Color Cosmetic Compositions And Methods | ELC MANAGEMENT LLC | 2011-09-15 | — | — | US | disclosed |
| EP-2364688-A2 | Cosmetic preparations with highly elastic texture | Beiersdorf AG (DE) | 2011-09-14 | — | — | EP | disclosed |
| EP-2230518-A1 | Method for analysis of saccharides | JCR Pharmaceuticals CO., LTD. (JP) | 2010-09-22 | — | — | EP | disclosed |
| US-20100233301-A1 | TOPICAL COMPOSITIONS COMPRISING FERMENTED EXTRACTS OF TRADITIONAL CHINESE MEDICINAL (TCM) INGREDIENTS, AND METHODS OF MAKING AND USING SAME | CHENG JING | 2010-09-16 | — | — | US | disclosed |
| US-20100229634-A1 | METHOD FOR ANALYSIS OF SACCHARIDES | JCR PHARMACEUTICALS CO., LTD. (JP) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110223219-A1 | Probiotic Color Cosmetic Compositions And Methods | CUTA, TYR, LPO | MPI 3611/4885PGD 1361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.